• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804250-15
Medical Device Problem Codes Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/04/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was to treat a 90%stenosed de novo lesion in the proximal left circumflex artery (lcx) with moderate calcification and heavy tortuosity.A 2.50x15mm non-abbott balloon was used for pre-dilatation.Then, the 2.50x15mm xience skypoint stent delivery system (sds) was attempted be advanced to the target lesion; however failed to cross due to the anatomy.Therefore, the sds was removed from the anatomy.However, during removal the stent became dislodged from the balloon in the lcx to the left main trunk artery.The stent was attempted to be removed with the guidewire (gw), but the stent was not able to be removed; therefore, a snare device was used to remove the stent.This ended the procedure and no additional treatment was provided.There was no adverse patient sequela.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.In this case, it is likely the device interacted with the moderately calcified, heavily tortuous and 90% stenosed lesion causing the reported failure to advance.During removal continued interaction with the difficult anatomy likely resulted in the reported stent dislodgement and subsequent treatment including stent removal using a snare device.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15870198
Report Number2024168-2022-11916
Device Sequence Number12076991
Product Code NIQ
UDI-Device Identifier08717648233074
UDI-Public08717648233074
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 11/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/11/2024
Device Model Number1804250-15
Device Catalogue Number1804250-15
Device Lot Number110054A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/04/2022
Initial Report FDA Received Date11/28/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/12/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-